Profit? PCK has been trying to commercialise and be cashflow neutral for 5 years and recently just did a CR even after the government grant they've received here those many years ago (I actually said PCK would have easily penetrated here given the RCA are already familiar with the APS assessments and be cashflow neutral so this has been very disappointing to say the least given the $20M government grant after they initially struggled to commercialise here without it).
Painface is only for procedural use so a short timeframe, if PCK charge by beds similar to Painchek were infant stay only a few days or weeks in hospital or clinic then I can't see how PCK can monetise this successfully so I've always saw this product as even more limited then Painchek.
IMU is already "tempting"There was no way I could buy the amount I wanted to invest without causing this to go to a bagger which was what @kenjikool did so I wouldn't have made a bagger......
Add to My Watchlist
What is My Watchlist?
